who should not take glp-1 receptor agonists – Peripheral Brain Glucagon-like peptide-1 receptor agonists and
Description
ColhounHLingvayIBrownPDeanfieldJBrown-FrandsenKKahnSet al

PMID: 54 NicolauJNadalASanchsPPujolATamayoMINadalCet al

Sandsdal et al

Human data are somewhat more reassuring for accidental early exposure, but there is still not enough evidence to recommend continuing these medications throughout pregnancy

Int J Obes (2026)

Phase 3 trials: Large scale clinical trials with data used to inform regulatory applications FDA approval: All new drugs in the US need the green light from the US Food and Drug Administration
